Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in early Parkinson's disease in China
NCT01556165Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Apr 2012
- Primary completion
- Dec 2013
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Lundbeck. Started Apr 2012; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01556165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556165.